Page last updated: 2024-08-24

repaglinide and Neuroblastoma

repaglinide has been researched along with Neuroblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ausserlechner, MJ; Geiger, K; Golderer, G; Huber, JM; Kiechl-Kohlendorfer, U; Lindner, H; Obexer, P; Salcher, S; Spoden, G	1

Other Studies

1 other study(ies) available for repaglinide and Neuroblastoma

Article	Year
Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells. Cells, 2019, 12-18, Volume: 9, Issue:1 Topics: Carbamates; Cell Line, Tumor; Cell Movement; Down-Regulation; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lumican; Neuroblastoma; Piperidines; Promoter Regions, Genetic; Protein Binding	2019

Article

Year

Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.

Cells, 2019, 12-18, Volume: 9, Issue:1

Topics: Carbamates; Cell Line, Tumor; Cell Movement; Down-Regulation; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lumican; Neuroblastoma; Piperidines; Promoter Regions, Genetic; Protein Binding

2019